You are leaving the Blue Earth Diagnostics website. By clicking this link, you will be taken to a website that is independent from Blue Earth Diagnostics. The site you are linking to is not controlled or endorsed by Blue Earth Diagnostics and Blue Earth Diagnostics is not responsible for the content provided on that site.

BEDUK-N/A-2500011  March 2025

 

ACCEPT CANCEL

THIS PAGE IS INTENDED FOR THE GENERAL PUBLIC AND HEALTHCARE PROFESSIONALS

You are leaving the Blue Earth Diagnostics corporate website. By clicking on YES below, you acknowledge that you are a patient based in the USA and will be redirected to a US product website that is independent of and not controlled by the owner of this website.

YES NO

UKBED-N/A-2600085 / May 2026

You are leaving the Blue Earth Diagnostics corporate website. By clicking on YES below, you acknowledge that you are a patient based in the USA and will be redirected to a US product website that is independent of and not controlled by the owner of this website.

YES NO

UKBED-N/A-2600085 / May 2026

You are leaving the Blue Earth Diagnostics corporate website. By clicking on YES below, you acknowledge that you are a patient based in the USA and will be redirected to a US product website that is independent of and not controlled by the owner of this website.

YES NO

UKBED-N/A-2600085 / May 2026

You are leaving the Blue Earth Diagnostics’ corporate website.

If you are a US healthcare professional please click on one of the following:

ACCEPT and go to www.axumin.com
ACCEPT and go to www.posluma.com
ACCEPT and go to www.wearecardiacpet.com

If you are not a US healthcare professional, please click on one of the following:

NO, I AM A PATIENT OR MEMBER OF THE GENERAL PUBLIC
NO, I AM A NON-US HEALTHCARE PROFESSIONAL
CANCEL

UKBED-N/A-2600112 / July 2026

You are leaving the Blue Earth Diagnostics corporate website.  By clicking on this link, you acknowledge that you are an HCP from the Republic of Korea and will be redirected to promotional content that is independent and not controlled by the owner of this website. 

YES NO

UKBED-N/A-2600004 / January 2026

You are leaving the Blue Earth Diagnostics corporate website.  By clicking on this link, you acknowledge that you are an HCP from Taiwan and will be redirected to promotional content that is independent and not controlled by the owner of this website.  

YES NO

UKBED-N/A-2600006 / January 2026

You are leaving the Blue Earth Diagnostics corporate website.  By clicking on this link, you acknowledge that you are an HCP from Japan and will be redirected to promotional content that is independent and not controlled by the owner of this website.  

YES NO

UKBED-N/A-2600005 / January 2026

PRODUCTS

Below is a list of our products, and their availability.  Not all products are available/approved in all countries.  Any information shared is provided in line with local regulations.  Due to regulatory requirements, we are unable to provide detailed information on our website. In markets where Blue Earth Diagnostics is not the marketing authorisation holder, the company has been responsible for development of products, but it is not involved in the promotion of products there. Cardiogen-82 is commercialized in collaboration with Bracco.

TRADEMARK
GENERIC NAME
PRODUCT AREA
LICENSED
MARKETING AUTHORISATION HOLDER
PATIENTS
HCPs

Axumin

fluciclovine F 18 injection

Oncology

US

Blue Earth Diagnostics Ltd

For patients based in the US, click here for more information

For HCPs based in the US, click here for more information

Axumin

fluciclovine (18F)

Oncology

Europe

Blue Earth Diagnostics Ireland Ltd

For patients based in Europe, click here for more information  

For HCPs based in Europe, click here for more information 

Axumin

fluciclovine (18F)

Oncology

UK

Blue Earth Diagnostics Ltd

For patients based in the UK, click here for more information  

For HCPs based in the UK, click here for more information

Cardiogen-82

Rubidium

Cardiology

Denmark

Bracco Imaging SpA

For patients based in Denmark, click here for more information  

For HCPs based in Denmark, click here for more information

Cardiogen-82

Rubidium

Cardiology

France

Bracco Imaging SpA

For patients based in France, click here for more information  

For HCPs based in France, click here for more information

Cardiogen

Rubidium

Cardiology

Italy

Bracco Imaging SpA

For patients based in Italy, click here for more information  

For HCPs based in Italy, click here for more information

Cardiogen-82

Rubidium

Cardiology

Switzerland

Bracco Suisse SA

For French speaking HCPs, click here for more information  

For Italian speaking HCPs, click here for more information  

For German speaking HCPs, click here for more information  

Cardiogen-82

Rubidium

Cardiology

Sweden

Bracco Imaging SpA

For patients based in Sweden, click here for more information  

For HCPs based in Sweden, click here for more information

Cardiogen-82

Rubidium

Cardiology

The Netherlands

Bracco Imaging SpA

For patients based in the Netherlands, click here for more information  

For HCPs based in the Netherlands, click here for more information

Cardiogen-82

Rubidium

Cardiology

UK

Bracco UK Ltd

For patients based in the UK, click here for more information  

For HCPs based in the UK, click here for more information

Cardiogen-82

Rubidium

Cardiology

US

Bracco Diagnostics Inc

For patients based in the US, click here for more information

For HCPs based in the US, click here for more information

Posluma

flotufolastat F 18 injection

Oncology

Taiwan

Global Medical Solutions Taiwan Ltd

For patients based in Taiwan, click here for more information

For HCPs based in Taiwan, click here for more information

Posluma

flotufolastat F 18 injection

Oncology

US

Blue Earth Diagnostics Ltd

For patients based in the US, click here for more information

For HCPs based in the US, click here for more information

Prostaseek

flotufolastat F 18 injection

Oncology

Republic of Korea

DuchemBio Co Ltd

For patients based in the Republic of Korea, click here for more information

For HCPs based in the Republic of Korea,  click here for more information

Downloadable Information for AXUMIN (fluciclovine 18f)

Summary of Product Characteristics

flags DOWNLOAD

Patient Information Leaflets

flags DOWNLOAD

Image Interpretation Training Materials

flags DOWNLOAD

UKBED-N/A-2600105 / July 2026